Posted on August 8, 2014
Ahhhh…summer! The sounds of food sizzling on the hot grill and the smell of barbecue fill the air. This time of the year is well known for outdoor events accompanied by a self-made grill master standing behind a fiery barbecue.
Grilling has received a bad reputation because of the possible link to an increased risk of colon cancer. But the joys and pleasure of consuming grilled food do not need to cause undue anxiety. The American Institute for Cancer Research (AICR) says it is most important to choose the right food to grill and it’s not necessary to avoid grilling altogether. Check out these helpful tips! Read more
Posted on August 4, 2014
“It isn’t cancer, is it?” asked David Prochnow to his doctor, half-jokingly. He was 35 at the time – healthy, active and happily married with two young children.
Before his doctor could respond, David knew. His worst fears were confirmed a few days later – stage III colorectal cancer. But David’s not alone -– nearly 15,000 people under age 50 are diagnosed every year. Read more
Posted on July 31, 2014
Exciting news in the colon cancer world! Last week, the experimental drug MGD007 was cleared by the FDA for Phase I clinical trials in colon cancer, scheduled to start later this year. MGD007 is different from other drugs currently available because it kills cancer cells in a different way. Specifically, it binds to a protein on immune system cells (or T-cells) and directs them to kill cells that express a protein found on 95% of primary and metastatic colon cancer cells. Read more
Posted on July 29, 2014
“There were people dressed as super heroes, somber families remembering loved ones lost and enthusiastic survivors celebrating their monumental fight. Although I could pick out my teammates from the crowd by their neon shirts, I felt alone. The emotion of the event overwhelmed me from the moment I arrived. It was a steamy day in downtown Philadelphia and my group of family and friends were joining me at the Colon Cancer Alliance’s Undy Run/Walk. It was the first thing colon cancer related event that I had ever participated in, and it was somewhere I never thought I would be.”
Posted on July 21, 2014
Study: Racial Disparity in Colon Cancer
Dr. John M. Carethers, a researcher at the University of Michigan Medical School, has conducted a study that may lead to concrete conclusions as to why African Americans have lower colon cancer survival rates. The study included African American and Caucasian colon cancer patients with a goal of determining if the groups had a genetic marker called microsatellite instability (MSI). Patients with MSI tumors have higher survival rates, and it was found that 14% of Caucasians and 7% of African-Americans had MSI colon cancer. Read more